tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AGIO Stock Latest News

Agios Pharmaceuticals announces new data on mitapivat
The FlyAgios Pharmaceuticals announces new data on mitapivat
5d ago
AGIO
Agios Pharmaceuticals’ Earnings Call: Growth and Challenges
PremiumCompany Announcements
Agios Pharmaceuticals’ Earnings Call: Growth and Challenges
7d ago
AGIO
Agios Pharmaceuticals Reports Q3 2025 Financial Results
PremiumCompany Announcements
Agios Pharmaceuticals Reports Q3 2025 Financial Results
8d ago
AGIO
Agios Pharma: Strong Market Performance and Promising Pipeline Justify Buy Rating
PremiumRatings
Agios Pharma: Strong Market Performance and Promising Pipeline Justify Buy Rating
9d ago
AGIO
Agios Pharma’s Strong Commercial Execution and Clinical Progress Drive Buy Rating
PremiumRatings
Agios Pharma’s Strong Commercial Execution and Clinical Progress Drive Buy Rating
9d ago
AGIO
Agios Pharmaceuticals reports Q3 EPS ($1.78), consensus ($1.90)
PremiumThe FlyAgios Pharmaceuticals reports Q3 EPS ($1.78), consensus ($1.90)
9d ago
AGIO
AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
AGIO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
11d ago
AGIO
Agios Pharmaceuticals Advances Sickle Cell Treatment with Tebapivat Study
Premium
Company Announcements
Agios Pharmaceuticals Advances Sickle Cell Treatment with Tebapivat Study
11d ago
AGIO
Agios Pharmaceuticals’ AG-236 Study: A Potential Game-Changer in Drug Development
PremiumCompany Announcements
Agios Pharmaceuticals’ AG-236 Study: A Potential Game-Changer in Drug Development
11d ago
AGIO
Agios Pharmaceuticals Advances Mitapivat Study for Sickle Cell Disease and Nephropathy
PremiumCompany Announcements
Agios Pharmaceuticals Advances Mitapivat Study for Sickle Cell Disease and Nephropathy
12d ago
AGIO
Agios Pharmaceuticals’ Promising Study on Tebapivat for Anemia in LR-MDS
PremiumCompany Announcements
Agios Pharmaceuticals’ Promising Study on Tebapivat for Anemia in LR-MDS
12d ago
AGIO
Agios Pharmaceuticals Ensures Continued Access to Mitapivat in New Study
PremiumCompany Announcements
Agios Pharmaceuticals Ensures Continued Access to Mitapivat in New Study
12d ago
AGIO
Agios Pharmaceuticals’ AG-181 Study: A Potential Game-Changer in Drug Development
PremiumCompany AnnouncementsAgios Pharmaceuticals’ AG-181 Study: A Potential Game-Changer in Drug Development
12d ago
AGIO
Positive Developments and Strategic Partnerships Bolster Agios Pharma’s Buy Rating
Premium
Ratings
Positive Developments and Strategic Partnerships Bolster Agios Pharma’s Buy Rating
22d ago
AGIO
Agios Pharmaceuticals receives positive CHMP opinion for PYRUKYND
Premium
The Fly
Agios Pharmaceuticals receives positive CHMP opinion for PYRUKYND
22d ago
AGIO
Agios Pharmaceuticals falls -13.3%
PremiumThe Fly
Agios Pharmaceuticals falls -13.3%
2M ago
AGIO
H.C. Wainwright still confident in approval of Agios’ Pyrukynd despite delay
PremiumThe Fly
H.C. Wainwright still confident in approval of Agios’ Pyrukynd despite delay
2M ago
AGIO
Agios Pharmaceuticals price target lowered to $51 from $52 at BofA
PremiumThe Fly
Agios Pharmaceuticals price target lowered to $51 from $52 at BofA
2M ago
AGIO
Agios Pharmaceuticals falls -14.4%
PremiumThe Fly
Agios Pharmaceuticals falls -14.4%
2M ago
AGIO
Agios Pharmaceuticals provides update on U.S. PDUFA goal date for PYRUKYND
PremiumThe FlyAgios Pharmaceuticals provides update on U.S. PDUFA goal date for PYRUKYND
2M ago
AGIO
Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
Premium
Ratings
Positive Outlook for Agios Pharma Despite Recent Patient Deaths Unrelated to Pyrukynd Treatment
3M ago
AGIO
Agios Pharmaceuticals reports Pyrukynd approval by Saudi Food and Drug Authority
Premium
The Fly
Agios Pharmaceuticals reports Pyrukynd approval by Saudi Food and Drug Authority
3M ago
AGIO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >